Drugs, hormones and ECT in childbearing women with psychiatric disorders

Psychiatry

Volumn 5, Issue 1, 2006, Pages 25-28

  Wieck, Angelika ^a   Gregoire, Alain ^b  

^a Northwest Perinatal Psychiatry Service   (United Kingdom)

^b NONE

Author keywords

anti epileptics; antipsychotics; ECT; perinatal psychiatry; psychiatric disorders in pregnancy; psychotropic drugs; teratogenicity; treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; DOSULEPIN; ESTRADIOL; FLUOXETINE; FOLIC ACID; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PROGESTERONE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TERATOGENIC AGENT; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ADAPTATION; APNEA; AROUSAL; ARTICLE; BEHAVIOR; BIRTH WEIGHT; BREAST FEEDING; BREAST MILK; CLINICAL TRIAL; COGNITIVE DEVELOPMENT; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DEPRESSION; DISTRACTIBILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTONIA; EBSTEIN ANOMALY; ELECTROCONVULSIVE THERAPY; EPILEPSY; EXCITABILITY; FACE DYSMORPHIA; FEEDING DISORDER; FETUS DISEASE; FINGER MALFORMATION; GESTATIONAL AGE; GOITER; GROWTH RETARDATION; HEART ARRHYTHMIA; HIGH RISK PREGNANCY; HUMAN; HYPERTHYROIDISM; HYPOGLYCEMIA; INTELLIGENCE QUOTIENT; LACTATION; LANGUAGE DEVELOPMENT; LIVER TOXICITY; LOW DRUG DOSE; MATERNAL DISEASE; MENTAL DISEASE; MENTAL PATIENT; META ANALYSIS; MICROCEPHALY; MONOTHERAPY; MOOD; MOTOR DYSFUNCTION; MUSCLE TONE; NERVOUSNESS; NEURAL TUBE DEFECT; NEWBORN DISEASE; PARKINSONISM; POSTNATAL CARE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; RESTLESSNESS; RISK ASSESSMENT; RISK REDUCTION; SCHIZOPHRENIA; SIDE EFFECT; SKIN MANIFESTATION; SPONTANEOUS ABORTION; STILLBIRTH; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; TEMPERAMENT; TERATOGENESIS; TERATOGENICITY; THERMOREGULATION; THYROID DISEASE; TOE MALFORMATION; TREATMENT RESPONSE; TREMOR; UNPLANNED PREGNANCY; UNSPECIFIED SIDE EFFECT; VITAMIN K DEFICIENCY; WITHDRAWAL SYNDROME;

EID: 33845352274     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.2006.5.1.25     Document Type: Article

References (13)

1. Cohen L., Friedman J., Jefferson J., Johnson E., and Weiner M. A re-evaluation of risk of in utero exposure to lithium. JAMA 271 (1994) 146-150
2. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 54 (1976) 193-197
3. National Institute for Clinical Excellence. Clinical Guideline 20. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. (2004), NICE, London
4. Adab N., Kini U., Vinten J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 (2004) 1575-1583
5. Altshuler L., Cohen L., Szuba M., Burt V., Gitlin M., and Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153 (1996) 592-606
6. Einarson T., and Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf (2005; Mar 1)
7. Nulman I., Rovet J., Stewart D., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336 (1997) 258-262
8. Bazire S. Psychotropic drug directory 2005/6 (2005), Quay Books, Salisbury
9. Haddad P., Pal B., Clarke P., Wieck A., and Sridhiran S. Neonatal symptoms Following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?. J Psychopharmacol 19 (2005) 554-557
10. Sanz E., Cuevas C., Kiuru A., Bate A., and Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365 (2005) 482-487
11. In: Taylor D., McConnell C., McConnell H., Abel K., and Kerwin R. (Eds). The Maudsley prescribing guidelines. 8th ed. (2005), Martin Dunitz, London
12. Wieck A. Teratogenic syndromes. In: Haddad P., Dursun S., and Deakin J. (Eds). Adverse syndromes and psychiatric drugs (2004), Oxford University Press, Oxford
13. Yonkers K., Wisner K., Stowe Z., et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 161 (2004) 608-620